Tag: Novo Nordisk

Novo Nordisk signs $3.3bn deal to acquire Dicerna Pharmaceuticals

pallavi123- November 19, 2021

Novo Nordisk has signed a deal worth around $3.3 billion to acquire Dicerna Pharmaceuticals, a US-based biotech company focused on developing ribonucleic acid interference (RNAi) ... Read More

Novo Nordisk gets Saxenda FDA updated label to cover obesity treatment in adolescents

pharmanewsdaily- December 6, 2020

Novo Nordisk has been given approval from the US Food and Drug Administration (FDA) for an updated label for Saxenda (liraglutide) injection 3 mg for ... Read More

Novo Nordisk to acquire US drug delivery company Emisphere Technologies

pharmanewsdaily- November 6, 2020

Danish pharma company Novo Nordisk has agreed to acquire US drug delivery company Emisphere Technologies in a deal worth $1.8 billion. The proprietary drug delivery ... Read More

Novo Nordisk to acquire cardio-renal disease company Corvidia Therapeutics

pharmanewsdaily- June 14, 2020

Novo Nordisk acquisition of Corvidia : Danish pharma company Novo Nordisk has agreed to acquire Corvidia Therapeutics from life sciences venture capital firm Sofinnova Partners ... Read More

Novo Nordisk acquires glucose binding molecules developer Ziylo

pallavi123- August 24, 2018

Novo Nordisk acquisition of Ziylo : Danish pharma company Novo Nordisk  has acquired Ziylo, a University of Bristol spin-out biotechnology company, in a deal that ... Read More

Novo Nordisk bags insulin aspart injection Fiasp FDA approval for diabetes

pharmanewsdaily- October 2, 2017

Fiasp FDA approval : Danish pharmaceutical company Novo Nordisk has secured the US FDA approval for its new fast-acting mealtime insulin aspart injection Fiasp 100 ... Read More

Novo Nordisk wins FDA approval of Victoza for heart diseases in type 2 diabetes

pallavi123- August 26, 2017

FDA approval of Victoza : Danish pharma giant Novo Nordisk diabetes drug Victoza (liraglutide) has been approved by the U.S. Food and Drug Administration (FDA) ... Read More

Novo Nordisk diabetes drug Victoza bags FDA approval for heart diseases

pharmanewsdaily- August 26, 2017

Danish pharma firm Novo Nordisk has secured the approval from the U.S. Food and Drug Administration (FDA) for using its diabetes drug Victoza (liraglutide) to ... Read More